Straubing / Germany, July 2007
Dear Friends,
Many parts of the world are enjoying the summer holiday season. I hope the unusual global weather is not spoiling your summer and you are able to enjoy some time away from work. I would like to take this opportunity to highlight some ISC associated meetings that will take place after the summer.
The patient Safety Congress has been organised by the GCC (States) Centre for Infection Control and Arab Health in collaboration with the ISC. The congress is split in two: “Infection Control” and “Decontamination & Sterilisation: Quality Management and Standards in CSSD”. Chair of the Scientific Committee is Dr. Ziad Memish. For further information, please go to http://www.ah-patientsafety.com
29 – 30 October. APUA 2nd World Conference: Devising Improved Methods for Identification and Treatment of Infectious Diseases. Boston, USA
This congress has been organized by the Alliance for the Prudent Use of Antibiotics and is supported by the ISC. In particular, ISC has organized the symposium on “Future strategies in drug development and prescribing”. For further information, go to http://www.tufts.edu/med/apua/
This congress on anti-cancer drugs is organised by the Turkish Society of Chemotherapy in conjunction with ISC. Abstract deadline is 15th September 2007.
For further information go to http://www.kongresist.com/
Further information is available via the conference organizer:
www.imedex.com
15-17 November. New developments in cancer management. Toronto, Canada
This meeting has been co-organised by the ISC Cancer Section and is the joint 4th ISC International Conference on Cancer Therapeutics and 7th Princess Margaret Hospital Conference:
Topics to be covered include:
* Latest advances in chemotherapy and surgical options
* The role of medical imaging in cancer diagnosis and treatment
* In depth examination of currently available and future targeted agents: Interpretation of clinical trials and application to clinical practice
* Managing toxicities of targeted therapies
* Molecular mechanisms of new cancer therapeutics.
21-24 November. Antibiotic Resistance. The Gambia
ISC is very pleased to announce a new network initiative in Africa. This will involve organising a series of meetings on “current issues with infection in Africa”.. The first will be held in collaboration with Mangosteen, which has several years experience in organising successful meetings in West Africa. It is a unique chance for people from around the world to come and present their own experiences, comparing and contrasting these with local presentations and state-of-the-art from acknowledged experts in the field. The friendly, informative atmosphere with group discussions and a beautiful venue will allow for a relaxed but informative and extremely enjoyable experience. Further information available at www.mangosee.com/antibiotics2007
This conference will be an important opportunity for scientists and physicians to meet who are involved in laboratory, translational and clinical research in the field of drug treatment of cancer.
The Congress has been organised under the auspices of the International Society of Chemotherapy.Further information available at www.everywheretravel.it/sic2007
26th ICC Toronto Canada (8 – 21 June 2009)
Initial proposals for the programme should be received no later than 10 September 2007 from ISC affiliated societies and the ISC Working Groups. To receive a proposal form, please contact ISC@abdn.ac.uk
Professor Kurt G. Naber
President of ISC
kurt.naber@nabers.de